Displaying results 13 - 24 of 88

Display:

12 24 48

Public Health and Advocacy

EASL Policy Dialogues S3 E8: Tackling Alcohol Harm: Lessons from Ireland and Europe

EASL Policy Dialogues

View

Public Health and Advocacy

EASL Policy Dialogues S3 E7: Transforming Liver Health in Europe: Policy, Prevention, and Cancer Screening Initiatives

EASL Policy Dialogues

View

General Hepatology

EASL Studio S3 E5: JHEP Live: Stigma and alcohol

EASL Studio

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - FR

PDF

View

Viral Hepatitis

EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022

EASL Studio

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - GE

PDF

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - CZ

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - GE

PDF

View

Public Health and Advocacy

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - RU

PDF

View

Public Health and Advocacy

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - CZ

PDF

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - EN

PDF

View

COVID-19 and the liver

EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Tr...

PDF

View

Displaying results 13 - 24 of 88

Display:

12 24 48